Business Description
Brawn Biotech Ltd
ISIN : INE899B01015
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.3 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 1.24 | |||||
Beneish M-Score | -2.8 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -23.7 | |||||
3-Year EBITDA Growth Rate | -65.3 | |||||
3-Year EPS without NRI Growth Rate | -31.2 | |||||
3-Year Book Growth Rate | -16.8 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 63.96 | |||||
9-Day RSI | 60.74 | |||||
14-Day RSI | 58.97 | |||||
6-1 Month Momentum % | -12.04 | |||||
12-1 Month Momentum % | 5.67 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.35 | |||||
Quick Ratio | 0.86 | |||||
Cash Ratio | 0.15 | |||||
Days Inventory | 145.37 | |||||
Days Sales Outstanding | 130.79 | |||||
Days Payable | 204.08 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 4.69 | |||||
Operating Margin % | -14.59 | |||||
Net Margin % | -12.01 | |||||
FCF Margin % | -0.3 | |||||
ROE % | -30.47 | |||||
ROA % | -11.36 | |||||
ROIC % | -28.6 | |||||
3-Year ROIIC % | 17.28 | |||||
ROC (Joel Greenblatt) % | -39.64 | |||||
ROCE % | -28.49 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shiller PE Ratio | 35.38 | |||||
PS Ratio | 0.6 | |||||
PB Ratio | 1.73 | |||||
Price-to-Tangible-Book | 1.73 | |||||
EV-to-EBIT | -3.93 | |||||
EV-to-EBITDA | -4.18 | |||||
EV-to-Revenue | 0.55 | |||||
EV-to-FCF | -183.8 | |||||
Price-to-Projected-FCF | 3.25 | |||||
Price-to-Median-PS-Value | 2.2 | |||||
Price-to-Net-Current-Asset-Value | 2.17 | |||||
Earnings Yield (Greenblatt) % | -25.45 | |||||
FCF Yield % | -0.51 | |||||
Forward Rate of Return (Yacktman) % | 9.46 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Brawn Biotech Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 126.836 | ||
EPS (TTM) (₹) | -4.963 | ||
Beta | 0.37 | ||
Volatility % | 48.76 | ||
14-Day RSI | 58.97 | ||
14-Day ATR (₹) | 1.251629 | ||
20-Day SMA (₹) | 22.807 | ||
12-1 Month Momentum % | 5.67 | ||
52-Week Range (₹) | 14.63 - 27.82 | ||
Shares Outstanding (Mil) | 3 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Brawn Biotech Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Brawn Biotech Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Brawn Biotech Ltd Frequently Asked Questions
What is Brawn Biotech Ltd(BOM:530207)'s stock price today?
When is next earnings date of Brawn Biotech Ltd(BOM:530207)?
Does Brawn Biotech Ltd(BOM:530207) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |